伴破骨细胞样巨细胞乳腺癌1例

doi:10.3760/cma.j.cn441417-20241223-16029

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (16): 2785-2788.DOI: 10.3760/cma.j.cn441417-20241223-16029

伴破骨细胞样巨细胞乳腺癌1例

周娜侯祾峰刘瑞发王思佳朱玉红

滨州医学院附属医院病理科，滨州 256603

收稿日期:2024-12-23 出版日期:2025-08-15 发布日期:2025-08-28
通讯作者: 朱玉红，Email：zyh691220@126.com
基金资助:
山东省自然科学基金（ZR2020MH243）

Breast carcinoma complicated with osteoclast-like giant cells: a case report

Zhou Na, Hou Lingfeng, Liu Ruifa, Wang Sijia, Zhu Yuhong

Pathology Department, Binzhou Medical University Hospital, Binzhou 256603, China

Received:2024-12-23 Online:2025-08-15 Published:2025-08-28
Contact: Zhu Yuhong, Email: zyh691220@126.com
Supported by:
Natural Science Foundation of Shandong Province (ZR2020MH243)

摘要/Abstract

摘要：

本文报道滨州医学院附属医院收治的1例伴破骨细胞样巨细胞乳腺癌患者。患者为42岁女性，因“左乳腺癌”入院。先前于东营市河口区妇幼保健院行乳腺肿物旋切术，体格检查发现双乳呈微创术后改变，乳腺超声显示双侧乳腺低回声（BI-RADS4类）。入院后行左乳癌改良根治术。借调东营市河口区妇幼保健院病理蜡块，病理提示伴破骨细胞样巨细胞乳腺癌。

关键词:

乳腺肿瘤, 破骨细胞样巨细胞, 临床病理, 鉴别诊断

Abstract:

The paper reports one patient with breast carcinoma and osteoclast-like giant cells treated at Binzhou Medical University Hospital. The patient was a 42-year-old woman, and was admitted to the hospital because of left-sided breast carcinoma. She previously underwent rotational excision of a breast mass at Maternal and Child Health Hospital at Hekou District, Dongying. The physical examination revealed postmitotic changes in both breasts, and the breast ultrasound showed bilateral breast hypoechoicity (BI-RADS category 4). The pathological wax blocks were borrowed from Maternal and Child Health Hospital at Hekou District, Dongying, and the pathological examination confirmed breast carcinoma complicated with osteoclast-like giant cells.

Key words:

Breast cancer, Osteoclast-like giant cells, Clinical pathology, Differential diagnosis

周娜侯祾峰刘瑞发王思佳朱玉红.

伴破骨细胞样巨细胞乳腺癌1例 [J]. 国际医药卫生导报, 2025, 31(16): 2785-2788.

Zhou Na, Hou Lingfeng, Liu Ruifa, Wang Sijia, Zhu Yuhong.

Breast carcinoma complicated with osteoclast-like giant cells: a case report [J]. International Medicine and Health Guidance News, 2025, 31(16): 2785-2788.

参考文献

[1] Holland R, van Haelst UJ. Mammary carcinoma with osteoclast-like giant cells. Additional observations on six cases[J]. Cancer, 1984, 53(9): 1963-1973. DOI:10.1002/1097-0142(19840501)53:9<1963::aid-cncr2820530927>3.0.co;2-n.
[2] Cai N, Koizumi J, Vazquez M. Mammary carcinoma with osteoclast-like giant cells: a study of four cases and a review of literature[J]. Diagn Cytopathol, 2005, 33(4): 246-251. DOI: 10.1002/dc.20341.
[3] Cai G, Simsir A, Cangiarella J. Invasive mammary carcinoma with osteoclast-like giant cells diagnosed by fine-needle aspiration biopsy: review of the cytologic literature and distinction from other mammary lesions containing giant cells[J]. Diagn Cytopathol, 2004, 30(6): 396-400. DOI: 10.1002/dc.20069.
[4] Wang YJ, Huang CP, Hong ZJ, et al. Invasive breast carcinoma with osteoclast-like stromal giant cells: a case report[J]. World J Clin Cases, 2023, 11(7): 1521-1527. DOI:10.12998/wjcc.v11.i7.1521.
[5] Rosen PP. Multinucleated mammary stromal giant cells: a benign lesion that simulates invasive carcinoma[J]. Cancer, 1979, 44(4): 1305-1308. DOI: 10.1002/1097-0142(197910)44:4<1305::aid-cncr2820440421>3.0.co;2-8.
[6] Cserni G. Histological type and typing of breast carcinomas and the WHO classification changes over time[J]. Pathologica, 2020, 112(1): 25-41. DOI: 10.32074/1591-951X-1-20.
[7] Zhou S, Yu L, Zhou R, et al. Invasive breast carcinomas of no special type with osteoclast-like giant cells frequently have a luminal phenotype[J]. Virchows Arch, 2014, 464(6): 681-688 DOI: 10.1007/s00428-014-1573-y.
[8] 孟云霄,姜英,卢朝辉,等. 伴破骨细胞样巨细胞的上皮性肿瘤[J]. 中华病理学杂志, 2010, 39(9): 642-645. DOI:10.3760/cma.j.issn.0529-5807.2010.09.020.
[9] 朱晓蔚,刘福兴,戴桂红,等. 伴破骨细胞样巨细胞的乳腺癌二例临床病理分析[J]. 肿瘤研究与临床, 2020, 32(2): 122-125. DOI:10.3760/cma.j.issn.1006-9801.2020.02.011.
[10] 丁华野,皋岚湘. 伴破骨细胞样巨细胞的乳腺癌[J]. 临床与实验病理学杂志, 2002, 18(3): 238-240. DOI:10.3969/j.issn.1001-7399.2002.03.002.
[11] Vicandi B, Jimenez-Heffernan JA, Lopez-Ferrer P, et al. Fine needle aspiration cytology of mammary carcinoma with osteoclast-like giant cells[J]. Cytopathology, 2004, 15(6): 321-325. DOI: 10.1111/j.1365-2303.2004.00166.x.
[12] Ohashi R, Hayama A, Matsubara M, et al. Breast carcinoma with osteoclast-like giant cells: a cytological-pathological correlation with a literature review[J]. Ann Diagn Pathol, 2018, 33: 1-5. DOI: 10.1016/j.anndiagpath.2017.11.003.
[13] Niu Y, Liao X, Li X, et al. Breast carcinoma with osteoclastic giant cells: case report and review of the literature[J]. Int J Clin Exp Pathol, 2014, 7(4): 1788-1791.
[14] Ofri A, Noushi F, O'Toole S. Invasive breast carcinoma with osteoclast-like giant cells (OLGC): a rare entity causing diagnostic confusion[J]. Breast J, 2020, 26(9): 1831-1832. DOI: 10.1111/tbj.13890.
[15] Athanasou NA, Wells CA, Quinn J, et al. The origin and nature of stromal osteoclast-like multinucleated giant cells in breast carcinoma: implications for tumour osteolysis and macrophage biology[J]. Br J Cancer, 1989, 59(4): 491-498. DOI: 10.1038/bjc.1989.102.
[16] 陈海玲,魏兵,步宏,等. 伴破骨细胞样巨细胞或反应性肉芽肿的乳腺癌[J]. 临床与实验病理学杂志, 2007, 23(2): 137-142. DOI:10.3969/j.issn.1001-7399.2007.02.003.
[17] Neelam S, Sanjay G. Invasive duct carcinoma of the breast with multinucleated osteoclast-like giant cells: a rare case diagnosed on fine needle aspiration cytology[J]. Breast J, 2012, 18(6): 596-597. DOI: 10.1111/tbj.12015.
[18] Shishido-Hara Y, Kurata A, Fujiwara M, et al. Two cases of breast carcinoma with osteoclastic giant cells: are the osteoclastic giant cells pro-tumoural differentiation of macrophages?[J]. Diagn Pathol, 2010, 5: 55. DOI: 10.1186/1746-1596-5-55.
[19] Turgeman I, Flechter E, Vlodavsky E, et al. Fortuitous administration of denosumab in breast carcinoma with osteoclastic giant cells[J]. Anticancer Drugs, 2018, 29(5): 466-470. DOI: 10.1097/CAD.0000000000000612.
[20] Ohashi R, Yanagihara K, Namimatsu S, et al. Osteoclast-like giant cells in invasive breast cancer predominantly possess M2-macrophage phenotype[J]. Pathol Res Pract, 2018, 214(2): 253-258. DOI: 10.1016/j.prp.2017.11.002.
[21] Tiainen S, Tumelius R, Rilla K, et al. High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer[J]. Histopathology, 2015, 66(6): 873-883. DOI: 10.1111/his.12607.
[22] Yamaguchi T, Fushida S, Yamamoto Y, et al. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination[J]. Gastric Cancer, 2016, 19(4): 1052-1065. DOI: 10.1007/s10120-015-0579-8.
[23] Perez-Alonso P. Breast carcinoma with osteoclast-like giant cells diagnosed by fine-needle aspiration cytology[J]. Diagn Cytopathol, 2012, 40(2): 148-149. DOI: 10.1002/dc.21615.
[24] Albawardi AS, Awwad AA, Almarzooqi SS. Mammary carcinoma with osteoclast-like giant cells: a case report[J]. Int J Clin Exp Pathol, 2014, 7(12): 9038-9043.
[25] 杨少秀,张爱兵. 伴破骨细胞样巨细胞乳腺癌临床病理分析[J]. 华北煤炭医学院学报, 2009, 11(2): 166-167. DOI:10.3969/j.issn.1008-6633.2009.02.015.

伴破骨细胞样巨细胞乳腺癌1例

Breast carcinoma complicated with osteoclast-like giant cells: a case report

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 12

编辑推荐

Metrics

[1]	郭玉格刘维帅马平丽. 子宫内膜癌组织中增殖基因表达情况与患者病理及预后的关系 [J]. 国际医药卫生导报, 2025, 31(6): 954-959.
[2]	折文利徐鑫利李彦婷李新. 超声及临床病理特征对甲状腺乳头状癌Delphian淋巴结转移的诊断价值 [J]. 国际医药卫生导报, 2024, 30(17): 2951-2956.
[3]	张丽柯徐全晓李媛媛杨卫. 胃癌组织中NF-κB、PD-1、PD-L1的表达及其临床意义 [J]. 国际医药卫生导报, 2024, 30(15): 2519-2523.
[4]	孙静黄佳琛. 非小细胞肺癌中Cbl家族表达与临床病理及预后的关系 [J]. 国际医药卫生导报, 2024, 30(13): 2174-2180.
[5]	李德正段红亮吴云桦魏志力徐玉. ST6Gal1与结直肠癌患者临床病理特征及预后的相关性 [J]. 国际医药卫生导报, 2024, 30(11): 1882-1887.
[6]	刘素素王娜娜常文丽司航石文雅张骞. 眼眶原发性脂肪肉瘤1例及临床病理分析 [J]. 国际医药卫生导报, 2024, 30(10): 1720-1725.
[7]	梅嘉洺杨育生. 直肠黏膜施万细胞错构瘤3例临床病理分析 [J]. 国际医药卫生导报, 2023, 29(7): 995-998.
[8]	丁佰娟张立伟杨慧崔秀娟李南. IGSF9在上皮性卵巢癌中的表达及对卵巢癌细胞转移能力的影响 [J]. 国际医药卫生导报, 2023, 29(16): 2268-2272.
[9]	谢丽赵昌乾王媛媛刘海娟. 超声引导下甲状腺细针穿刺细胞涂片对4A类甲状腺结节良恶性的鉴别诊断价值 [J]. 国际医药卫生导报, 2023, 29(15): 2158-2162.
[10]	唐雪珂曲其志许丹. 高分辨血管壁MRI对鉴别动脉粥样硬化和急性动脉炎的诊断价值 [J]. 国际医药卫生导报, 2023, 29(12): 1688-1692.
[11]	杨汉顾玉兰. 神经纤毛蛋白-1在胃癌组织中的表达与临床病理特征及预后相关性的meta分析[J]. 国际医药卫生导报, 2022, 28(22): 3246-3251.
[12]	刘悦. 化脓性肉芽肿的研究进展及误诊概况分析[J]. 国际医药卫生导报, 2022, 28(1): 140-144.